|
Raw Material Medicine Manufacturing
|
US$
100 |
|
Jul-2022 |
Doc　#36540 |
|
| Printed Page Length :
15
pages |
| Number of Tables :
3 |
| Number of Figures:
1 |
|
Market Overview
|
|
Demand in the end market remains strong, suggesting active pharmaceutical ingredient firms with niche products will benefit from the restructuring process of the pharmaceutical supply chains in Europe and the United States and generic drug companies in Taiwan. Consequently, the industry climate will be slightly favorable in the second half of 2022.
|
|
|
|